999 Blog posts found


Determining Inherited Risk for Pediatric Cancers Can Benefit Patients and Families

A recent study highlights the importance of searching for inherited cancer genes in children with pediatric cancers.

Mother and child in hospital

In the Lab

A Netflix-Inspired Approach to Understanding Biology and Medicine

Computers currently help us choose our favorite movies, books, and TV shows. Will personalized medicines be next?

Researchers at MSK have devised a technique, based on machine learning, that can predict the DNA binding preferences of a protein called a transcription factor.

Ask the Expert

Early Detection of Breast Cancer Improves as Screening Tests Evolve

Learn about promising advances in breast cancer screening tests from Elizabeth Morris, MSK’s Breast Imaging Service Chief.

Three side-by-side imaging photos of breast tissue.

In the Clinic

Liquid Biopsy Shown to Be Effective in Assessing Response to Breast Cancer Drugs

Two studies show that a liquid biopsy, which analyzes tumor DNA in the blood, can reveal essential information about how breast cancers respond to therapies.

Hand in surgical glove holding up small beaker of blood.

In the Clinic

New Drug Combination Improves Outcomes in Patients with Chronic Lymphocytic Leukemia

An international study led by MSK shows that adding a drug called idelalisib to standard treatment increases survival.

Chronic lymphocytic leukemia cells


Understanding Jimmy Carter’s Surprise Cancer Turnaround: A Conversation with Jedd Wolchok

Former President Carter’s recent announcement that he is “cancer free” has generated a lot of media attention. Here, we tackle some of the science behind the story.

Former US President Jimmy Carter

In the Clinic

Innovative Research Center Will Explore Hereditary Cancer Genes

MSK’s new Robert and Kate Niehaus Center for Inherited Cancer Genomics is using the latest in gene sequencing technologies to discover the inherited causes of cancer.

Kenneth Offit


Immunotherapy Pioneered at MSK Receives FDA Approval for Advanced Kidney Cancer

Thanks to the work of MSK’s Robert Motzer, people with advanced renal cell carcinoma (a type of kidney cancer) now have a new immunotherapy option available to them.

Robert J. Motzer


A Computational Biologist Explains How Cancer Patient Data Leads to Personalized Medicine

Researcher Barry Taylor discusses the importance of understanding the function of individual mutations found in patients’ tumors.

Barry Taylor sitting at a desk.


Colorectal Cancer Screening Rate Skyrockets in NYC with Help from MSK Physician

An NYC initiative to increase screening for colorectal cancer has produced stunning results.

Colonic Adenocarcinoma with H&E Staining